Dear Editor,
The Health Information and Quality Authority (Hiqa) concluded on the 19th of July that incorporating shingles vaccination to the standard immunisation regimen for individuals 50 years old and above isn’t efficient use of HSE resources, considering the current pricing. Yet, is Hiqa aware that the state incurs costs for antiviral treatment during shingles infection and consecutive therapies for post herpetic neuralgia?
The major fiscal burden on the nation arises from the impairment in the quality of life experienced by senior citizens stricken with shingles. How many amongst us are in a position to dispense up to €600 for shingles inoculation?
In a disparate matter, Elon Musk will not contribute to Donald Trump’s profit. I also had an unforgettable five-day journey in Estonia, replete with saunas, bears, and wolves. Moreover, in August, join me in discovering the top 10 new series on Netflix, Prime Video, Disney+, and Apple TV+.
Join the discussion: What was your top highlight from the 2024 Olympic games?
It’s imperative for vaccine producers to decrease their prices for the country. Let’s not even begin to discuss the expense of the chickenpox vaccine administered to children!
Yours faithfully,
Michelle Anderson, MPSI,
Blackrock,
Co Dublin.